Welcome to Targanta Therapeutics Printer Friendly Version

George A. Eldridge
Senior Vice President Finance and Administration and Chief Financial Officer

George Eldridge joined Targanta Therapeutics in September 2006 from Therion Biologics, a privately held cancer vaccines company, where he served as Senior Vice President and Chief Financial Officer. Prior to joining Therion in 2002, George served as Vice President of Finance and Chief Financial Officer of Curis (three-way merger among Creative BioMolecules, Ontogeny, and Reprogenesis) from 1996-2002.

Prior to joining Ontogeny in 1996, George was Chief Financial Officer for Boston Life Sciences, Inc., and was prior to that an investment banker at Kidder Peabody & Co., Inc. George earned a M.B.A. from the University of Chicago, and a B.A. in government and economics from Dartmouth College.